Neurovascular Embolization Devices (Neurology Devices) - Global Market Analysis and Forecast Model

  • ID: 4544587
  • Report
  • Region: Global
  • GlobalData
1 of 3

FEATURED COMPANIES

  • Acandis GmBH
  • B. Braun
  • BALT Extrusion
  • Emboflu
  • KLS Martin
  • Medtronic Plc
  • MORE
Neurovascular Embolization Devices (Neurology Devices) - Global Market Analysis and Forecast Model

Summary

Neurovascular Embolization Devices (Neurology Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Neurology therapeutic area.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis. Moreover, analyst comments with qualitative insight offer context for quantitative data.

Neurovascular Embolization Devices are used to treat abnormalities in blood vessels in the brain, namely, Brain Aneurysms and Arteriovenous Malformations (AVM). These devices occlude or prevent blood flow to unwanted vessel malformations. The neurosurgical approach for Brain Aneurysms includes Aneurysm Clips, which occlude the aneurysm, cutting blood flow in. Neurovascular treatment includes Embolization Coiling, which is where the aneurysm is filled with microcoils to prevent blood flow; and Flow Diversion Stents, which are placed within the blood vessel with the aneurysm and diverting blood flow past the aneurysm. AVMs are largely treated using liquid embolic systems, as well as Embolization Coiling for more complicated cases such as dual AVMs.

Key Inclusions of the market model

Currently marketed Neurovascular Embolization Devices and evolving competitive landscape:
  • Insightful review of the key industry trends.
  • Annualized total Neurovascular Embolization Devices market revenue by segment and market outlooks from 2015-2028.
  • Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights:
  • Qualitative market specific information is available with global and regional trends further broken down into country specific insights on the market.
  • SWOT analysis for Neurovascular Embolization Devices market.
  • Competitive dynamics insights and trends provided for Neurovascular Embolization Devices market.
Understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
  • CMO executives who must have deep understanding of the neurovascular embolization devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to buy

The model will enable you to:
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving neurovascular embolization devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the neurovascular embolization devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific neurovascular embolization devices market from 2015-2028.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
READ MORE
Note: Product cover images may vary from those shown
2 of 3

Loading
LOADING...

3 of 3
  • Acandis GmBH
  • B. Braun
  • BALT Extrusion
  • Emboflu
  • Stryker
  • Johnson & Johnson (Cerenovus)
  • KLS Martin
  • Medtronic Plc
  • Mizuho Medical
  • Peter Lazic GmBH
  • Phenox GmBH
  • Terumo Corporation (MicroVention)
Note: Product cover images may vary from those shown
4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll